Nicolas U. Gerber

University Children's Hospital Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Ana S. Guerreiro Stucklin

University of Zurich

SWITZERLAND

View details

Birgit Geoerger

Université Paris-Saclay

FRANCE

View details

Semi Harrabi

University Hospital Heidelberg

GERMANY

View details

Denise Obrecht-Sturm

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Andre von Bueren

University Hospital of Geneva

SWITZERLAND

View details

Michael Capra

Consultant Paediatric Oncologist, Clinical Professor - Trinity College Dublin

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicolas U. Gerber

Research Interests

Explore related searches

Contact this professor

Articles (10)

Educational Attainment and Employment Outcome of Survivors of Pediatric CNS Tumors in Switzerland—A Report from the Swiss Childhood Cancer Survivor Study

Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes

Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial

Correction to: Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes.

Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.

Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial.

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.

Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.

Collaborators (6)

Ana S. Guerreiro Stucklin

Birgit Geoerger

Semi Harrabi

Denise Obrecht-Sturm

Andre von Bueren

Michael Capra

Make your next move.